Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer’s disease. https://t.co/9j2jgC9Orb
RT @agingdoc1: Preprint below now in print @AgingJrnl Aging the brain: multi-region methylation principal component based clock in the co…
RT @womensbrainpro: "Epigenetic clocks are promising tools for the quantification of biological aging, yet we hypothesize that investigatio…
RT @womensbrainpro: "Epigenetic clocks are promising tools for the quantification of biological aging, yet we hypothesize that investigatio…
RT @womensbrainpro: "Epigenetic clocks are promising tools for the quantification of biological aging, yet we hypothesize that investigatio…
Validated biomarkers of aging are critical for advancing clinical trials of age-retarding therapies.
"Epigenetic clocks are promising tools for the quantification of biological aging, yet we hypothesize that investigation of brain aging in AD will be assisted by the development of brain-specific epigenetic clocks." -@AgingJrnl https://t.co/1ti2SXqG25
Preprint below now in print @AgingJrnl Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer’s disease 👉https://t.co/4Di0Vc62cU Kyra Thrush, @DrMorganLevine & colleagues
Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer's disease https://t.co/JlVA8RoIbN
Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer’s disease | Aging https://t.co/iQyJaxpbaz
RT @DrMorganLevine: Congratulations Kyra. Great work! https://t.co/w7w2nQxgF7
Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer's disease https://t.co/vzHXv31TNC
New article: Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer's disease https://t.co/ivA1283YOh #alzheimers #neurology https://t.co/S72PuAR5lw
New in Pubmed: "Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer's disease" https://t.co/wIezblUSOK
RT @DrMorganLevine: Congratulations Kyra. Great work! https://t.co/w7w2nQxgF7
RT @DrMorganLevine: Congratulations Kyra. Great work! https://t.co/w7w2nQxgF7
RT @DrMorganLevine: Congratulations Kyra. Great work! https://t.co/w7w2nQxgF7
“PCBrainAge captures meaningful heterogeneity of aging: Its acceleration demonstrates stronger associations with clinical AD dementia, pathologic AD, and APOE ε4 carrier status compared to extant epigenetic age predictors.” Read it as a pre-print, great t
Congratulations Kyra. Great work! https://t.co/w7w2nQxgF7